Cadence Pharmaceuticals Inc., a prominent player in the biopharmaceutical industry, is headquartered in the United States. Founded in 2004, the company has made significant strides in developing innovative therapies, particularly in pain management and anaesthesia. Cadence is renowned for its flagship product, OFIRMEV, an intravenous formulation of acetaminophen, which has transformed pain relief protocols in hospitals. With a focus on enhancing patient care, Cadence Pharmaceuticals has established a strong market position, recognised for its commitment to quality and efficacy. The company operates primarily in North America, with a growing presence in international markets. Cadence's dedication to research and development continues to drive its success, positioning it as a leader in the pharmaceutical landscape.
We don't have data for Cadence Pharmaceuticals Inc., but we can show you information about their parent organization instead.
View parent company